CBSH
Commerce Bancshares, Inc.
CBSH's fundamentals are mixed: revenue grew 10%, but its operating margin fell 1 points to 41%. At 14x earnings, it's trading below its usual 16x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CBSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CBSH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CBSH.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CBSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $53.32 | -4% |
| Forward | 13x | $55.57 | — |
| Current | 14x | $55.57 | — |
| Fair | 16x | $62.21 | +12% |
| Expensive | 19x | $75.69 | +36% |
Historical ranges are pointers, not guarantees.
CBSH's PE is in its cheap range at 14x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CBSH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
CBSH has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CBSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.43 | +11% |
| Q3 2026 | $4.00 | -1.2% |
| Q2 2026 | $3.98 | -0.7% |
| Q1 2026 | $4.02 | +3.3% |
| Q4 2025 | $4.04 | +8.3% |
| Q3 2025 | $4.05 | +15% |
| Q2 2025 | $4.01 | +18% |
| Q1 2025 | $3.89 | +18% |
| Q4 2024 | $3.73 | +12% |
CBSH has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CBSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $494.3M | +12% |
| Q2 2026 | $498.9M | +12% |
| Q1 2026 | $475.7M | +11% |
| Q4 2025 | $449.4M | +6.5% |
| Q3 2025 | $441M | +4.6% |
| Q2 2025 | $445.8M | +7.5% |
| Q1 2025 | $428.1M | +7.6% |
| Q4 2024 | $422.1M | +7.3% |
CBSH's revenue has grown year over year for 18 quarters in a row: $494M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | -0.9 points |
| Q2 2026 | 41% | -2.7 points |
| Q1 2026 | 39% | -0.2 points |
| Q4 2025 | 41% | -0.4 points |
| Q3 2025 | 42% | -0.5 points |
| Q2 2025 | 44% | +0.6 points |
| Q1 2025 | 39% | +2.2 points |
| Q4 2024 | 41% | +4.6 points |
CBSH has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CBSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $181M | +60% |
| Q2 2026 | $169.1M | +68% |
| Q1 2026 | $678.4M | +438% |
| Q4 2025 | $252.6M | +$403.3M |
| Q3 2025 | $113.3M | -73% |
| Q2 2025 | $100.5M | -28% |
| Q1 2025 | $126M | +1.2% |
| Q4 2024 | -$150.7M | -243% |
CBSH has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CBSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -1.9M shares |
| 1 year | +6.9% | +9.1M shares |
| 3 years | +3.3% | +4.5M shares |
| 5 years | +0.2% | +350K shares |
| Available history | -1% | -1.5M shares |
CBSH has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $110.7M |
| Q2 2026 | $112.1M |
| Q1 2026 | $84.3M |
| Q4 2025 | $115.3M |
| Q3 2025 | $25.2M |
| Q2 2025 | $11.9M |
| Q1 2025 | $55.2M |
| Q4 2024 | $46.9M |
CBSH spent $422M buying back its own shares over the past year, about three times what it spent the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CBSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
CBSH has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CBSH.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CBSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 24.3 | Neutral |
CBSH's weekly RSI is 49 (neutral) and its Stochastic is 24 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CBSH PE vs Financial Services Sector
| Metric | CBSH | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 6.7% above |
| PE % | 22 | 63 | 41 pts below |
CBSH is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CBSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.4 | 0.2% above |
| 20 week MA | $57.4 | 3.1% below |
| 50 week MA | $54.3 | 2.3% above |
| 100 week MA | $56.2 | 1.1% below |
| 200 week MA | $52.9 | 5.1% above |
CBSH has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CBSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.9 | $52.0 | +2.2% |
| 2021 | $52.0 | $56.0 | +7.7% |
| 2022 | $56.0 | $57.7 | +3% |
| 2023 | $57.7 | $48.4 | -16% |
| 2024 | $48.4 | $59.8 | +24% |
| 2025 | $59.8 | $53.0 | -11% |
| 2026 YTD | $53.0 | $55.6 | +4.9% |
CBSH has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.